ECM
HRTX icon

Element Capital Management’s Heron Therapeutics HRTX Stock Holding History

Element Capital Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,390
Closed -$234K – 757
2018
Q3 		$234K Buy
7,390
+1,416
+24% +$52.7K ﹤0.01% 696
2018
Q2 		$232K Buy
+5,974
New +$190K 0.01% 659

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Element Capital Management's HRTX Position: Q4 2018 in Review

Element Capital Management sold out of Heron Therapeutics (HRTX) in Q4 2018, closing a stake of 7,390 shares — an estimated $234K sold.

Element Capital Management first reported a position in HRTX in Q2 2018 and held it in 2 quarters. The position peaked at $234K in Q3 2018. 176 funds tracked by Wall St. Rank hold HRTX as of Q4 2018.

  • Element Capital Management reported no remaining Heron Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 7,390 Heron Therapeutics shares in Q4 2018, an estimated $234K.
  • Element Capital Management first reported a position in Heron Therapeutics in Q2 2018 and held it in 2 quarters.
  • Element Capital Management's Heron Therapeutics position peaked at $234K in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.